| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 1.33e-05 | 5 | 222 | 3 | GO:0052871 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 4.59e-05 | 7 | 222 | 3 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 4.59e-05 | 7 | 222 | 3 | GO:0018685 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 1.23e-04 | 2 | 222 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 1.23e-04 | 2 | 222 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 1.54e-04 | 10 | 222 | 3 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 1.54e-04 | 10 | 222 | 3 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 1.54e-04 | 10 | 222 | 3 | GO:0102033 | |
| GeneOntologyMolecularFunction | GTPase activator activity | ARHGAP32 GDI1 IQGAP1 ARHGEF6 RASA2 TBC1D8 ARHGAP5 RGS20 RANBP3L RABEP1 RAPGEF2 | 3.04e-04 | 279 | 222 | 11 | GO:0005096 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 3.57e-04 | 13 | 222 | 3 | GO:0016713 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | EXOC3 EVPL EPS8L1 IQGAP1 PTPN6 PTPRD PI4KA PLEC FERMT2 CNTN2 SELL KTN1 AHSA1 P4HB ICAM5 BCAM CDH3 | 4.04e-04 | 599 | 222 | 17 | GO:0050839 |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 5.31e-04 | 34 | 222 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization | 5.59e-04 | 15 | 222 | 3 | GO:0086008 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP32 GRIPAP1 EPS8L1 GDI1 IQGAP1 ARHGEF6 RASA2 RASGRF1 DIS3 TBC1D8 ARHGAP5 RGS20 RANBP3L RABEP1 RAPGEF2 | 5.78e-04 | 507 | 222 | 15 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP32 GRIPAP1 EPS8L1 GDI1 IQGAP1 ARHGEF6 RASA2 RASGRF1 DIS3 TBC1D8 ARHGAP5 RGS20 RANBP3L RABEP1 RAPGEF2 | 5.78e-04 | 507 | 222 | 15 | GO:0030695 |
| GeneOntologyMolecularFunction | protein kinase A catalytic subunit binding | 6.82e-04 | 16 | 222 | 3 | GO:0034236 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 7.28e-04 | 4 | 222 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 9.78e-04 | 18 | 222 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 1.31e-03 | 43 | 222 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | gated channel activity | KCNE5 RYR1 RYR3 ITPR3 KCNJ2 KCNJ8 SCN10A SLC17A7 CACNA2D1 GRIK2 CLCA2 | 1.34e-03 | 334 | 222 | 11 | GO:0022836 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.46e-03 | 193 | 222 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.67e-03 | 197 | 222 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 1.78e-03 | 199 | 222 | 8 | GO:1901981 | |
| GeneOntologyMolecularFunction | alkaline phosphatase activity | 1.79e-03 | 6 | 222 | 2 | GO:0004035 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.79e-03 | 6 | 222 | 2 | GO:0048763 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | MYH6 FADD NEB RXRA KCNJ8 COL14A1 FGFR2 PLEC SORBS2 NEBL GSK3A ZFPM2 PRKAR1A ALPK2 | 1.26e-05 | 327 | 221 | 14 | GO:0048738 |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 2.20e-05 | 177 | 221 | 10 | GO:0055007 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 2.37e-05 | 6 | 221 | 3 | GO:0036101 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | MYH6 FADD NEB RXRA KCNJ8 COL14A1 FGFR2 PLEC SORBS2 NEBL GSK3A ZFPM2 PRKAR1A ALPK2 | 2.59e-05 | 349 | 221 | 14 | GO:0014706 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 3.88e-05 | 36 | 221 | 5 | GO:0086010 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 4.11e-05 | 7 | 221 | 3 | GO:0036102 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell development | 5.17e-05 | 122 | 221 | 8 | GO:0055013 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 5.27e-05 | 62 | 221 | 6 | GO:0086002 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 6.53e-05 | 8 | 221 | 3 | GO:0036100 | |
| GeneOntologyBiologicalProcess | heart development | TMEM67 MYH6 ANKS6 FADD NEB RXRA RYR1 KCNJ8 PDS5A COL14A1 FGFR2 PLEC COL6A1 SORBS2 NEBL GSK3A ZFPM2 PRKAR1A KDM2A ALPK2 PCNT | 6.91e-05 | 757 | 221 | 21 | GO:0007507 |
| GeneOntologyBiologicalProcess | cardiac cell development | 9.03e-05 | 132 | 221 | 8 | GO:0055006 | |
| GeneOntologyBiologicalProcess | muscle cell development | MYH6 NEB RYR1 COL14A1 PLEC COL6A1 SORBS2 NEBL GSK3A PRKAR1A ALPK2 | 1.16e-04 | 259 | 221 | 11 | GO:0055001 |
| GeneOntologyBiologicalProcess | cardiocyte differentiation | 1.42e-04 | 221 | 221 | 10 | GO:0035051 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue development | 1.65e-04 | 76 | 221 | 6 | GO:0003229 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 1.88e-04 | 11 | 221 | 3 | GO:1901523 | |
| GeneOntologyBiologicalProcess | heart growth | 2.00e-04 | 148 | 221 | 8 | GO:0060419 | |
| GeneOntologyCellularComponent | sarcolemma | 2.25e-04 | 190 | 225 | 9 | GO:0042383 | |
| GeneOntologyCellularComponent | sarcoplasm | 2.37e-04 | 114 | 225 | 7 | GO:0016528 | |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH6 PECAM1 NEB RYR1 RYR3 KCNJ8 PLEC FERMT2 COL6A1 SORBS2 NEBL | 3.23e-04 | 290 | 225 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | collagen type VI trimer | 3.44e-04 | 3 | 225 | 2 | GO:0005589 | |
| GeneOntologyCellularComponent | collagen beaded filament | 3.44e-04 | 3 | 225 | 2 | GO:0098647 | |
| GeneOntologyCellularComponent | I band | 4.47e-04 | 166 | 225 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | apical part of cell | DNAAF11 IQGAP1 ITPR3 FAT1 PTPRQ MTCL1 PLEC USH2A SORBS2 CYP4F2 AQP5 CYP4F3 RAPGEF2 CYP4F11 CEACAM20 PCM1 | 7.16e-04 | 592 | 225 | 16 | GO:0045177 |
| GeneOntologyCellularComponent | myofibril | 7.85e-04 | 273 | 225 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | apical plasma membrane | IQGAP1 ITPR3 FAT1 PTPRQ MTCL1 PLEC USH2A SORBS2 CYP4F2 AQP5 CYP4F3 RAPGEF2 CYP4F11 CEACAM20 | 8.53e-04 | 487 | 225 | 14 | GO:0016324 |
| MousePheno | translucent skin | 9.06e-07 | 15 | 180 | 5 | MP:0001201 | |
| MousePheno | abnormal long-term potentiation | GRIPAP1 ATRX RYR3 PTPRD SLC17A7 ARHGEF6 RASGRF1 NBEA GRIK2 GRM1 TAMALIN ICAM5 PRKAR1B | 5.69e-06 | 221 | 180 | 13 | MP:0002207 |
| Domain | LRRC37AB_C | 7.02e-06 | 4 | 227 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 7.02e-06 | 4 | 227 | 3 | PF14914 | |
| Domain | LRRC37_N | 7.02e-06 | 4 | 227 | 3 | IPR032754 | |
| Domain | LRRC37 | 7.02e-06 | 4 | 227 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 7.02e-06 | 4 | 227 | 3 | IPR015753 | |
| Domain | RIH_assoc-dom | 3.45e-05 | 6 | 227 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 3.45e-05 | 6 | 227 | 3 | PF08709 | |
| Domain | RIH_assoc | 3.45e-05 | 6 | 227 | 3 | PF08454 | |
| Domain | RIH_dom | 3.45e-05 | 6 | 227 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.45e-05 | 6 | 227 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 3.45e-05 | 6 | 227 | 3 | IPR015925 | |
| Domain | - | 3.45e-05 | 6 | 227 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 3.45e-05 | 6 | 227 | 3 | PF01365 | |
| Domain | VWA | 5.90e-05 | 56 | 227 | 6 | PF00092 | |
| Domain | IQ_motif_EF-hand-BS | 1.13e-04 | 90 | 227 | 7 | IPR000048 | |
| Domain | IQ | 1.39e-04 | 93 | 227 | 7 | PS50096 | |
| Domain | Nuc_recep-AF1 | 1.47e-04 | 2 | 227 | 2 | PF11825 | |
| Domain | Nuc_recep-AF1 | 1.47e-04 | 2 | 227 | 2 | IPR021780 | |
| Domain | MIR | 2.00e-04 | 10 | 227 | 3 | PF02815 | |
| Domain | MIR_motif | 2.00e-04 | 10 | 227 | 3 | IPR016093 | |
| Domain | MIR | 2.00e-04 | 10 | 227 | 3 | PS50919 | |
| Domain | MIR | 2.00e-04 | 10 | 227 | 3 | SM00472 | |
| Domain | IQ | 2.24e-04 | 71 | 227 | 6 | PF00612 | |
| Domain | - | 2.81e-04 | 74 | 227 | 6 | 3.40.50.410 | |
| Domain | Ryanodine_rcpt | 4.38e-04 | 3 | 227 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 4.38e-04 | 3 | 227 | 2 | IPR009460 | |
| Domain | RyR | 4.38e-04 | 3 | 227 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 4.38e-04 | 3 | 227 | 2 | PF06459 | |
| Domain | Ryan_recept | 4.38e-04 | 3 | 227 | 2 | IPR013333 | |
| Domain | IQ | 4.58e-04 | 81 | 227 | 6 | SM00015 | |
| Domain | VWFA | 4.89e-04 | 82 | 227 | 6 | PS50234 | |
| Domain | VWA | 5.57e-04 | 84 | 227 | 6 | SM00327 | |
| Domain | IGc2 | PECAM1 CILP2 PTPRD FGFR2 CNTN2 CILP ICAM5 BCAM CEACAM20 ALPK2 | 6.24e-04 | 235 | 227 | 10 | SM00408 |
| Domain | Ig_sub2 | PECAM1 CILP2 PTPRD FGFR2 CNTN2 CILP ICAM5 BCAM CEACAM20 ALPK2 | 6.24e-04 | 235 | 227 | 10 | IPR003598 |
| Domain | PH_dom-like | EPS8L1 PTPN3 AFAP1L2 PLEKHA5 PLCD1 FERMT2 ARHGEF6 RASA2 RASGRF1 GRB14 NBEA CDC42BPB RANBP3L SNTG2 | 7.50e-04 | 426 | 227 | 14 | IPR011993 |
| Domain | Nebulin | 8.68e-04 | 4 | 227 | 2 | PF00880 | |
| Domain | NEBULIN | 8.68e-04 | 4 | 227 | 2 | PS51216 | |
| Domain | cAMP_dep_PK_reg_su | 8.68e-04 | 4 | 227 | 2 | IPR012198 | |
| Domain | NEBU | 8.68e-04 | 4 | 227 | 2 | SM00227 | |
| Domain | Nebulin | 8.68e-04 | 4 | 227 | 2 | IPR013998 | |
| Domain | Nebulin_repeat | 8.68e-04 | 4 | 227 | 2 | IPR000900 | |
| Domain | VWF_A | 1.32e-03 | 99 | 227 | 6 | IPR002035 | |
| Domain | FYrich_C | 1.44e-03 | 5 | 227 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.44e-03 | 5 | 227 | 2 | IPR003888 | |
| Domain | FYRC | 1.44e-03 | 5 | 227 | 2 | SM00542 | |
| Domain | FYRN | 1.44e-03 | 5 | 227 | 2 | SM00541 | |
| Domain | EXOC3/Sec6 | 1.44e-03 | 5 | 227 | 2 | IPR010326 | |
| Domain | Sec6 | 1.44e-03 | 5 | 227 | 2 | PF06046 | |
| Domain | FYRN | 1.44e-03 | 5 | 227 | 2 | PF05964 | |
| Domain | FYRC | 1.44e-03 | 5 | 227 | 2 | PF05965 | |
| Domain | FYRC | 1.44e-03 | 5 | 227 | 2 | PS51543 | |
| Domain | FYRN | 1.44e-03 | 5 | 227 | 2 | PS51542 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 SYNRG GRIPAP1 ATRX TRIM26 E2F7 EXOC3 ZNF217 RUVBL2 PTK6 PI4KA MCM3AP KIF14 CEP85 DIS3 GSK3A TBC1D8 RABEP1 SPEN GARRE1 PCM1 PCNT | 7.71e-11 | 588 | 230 | 22 | 38580884 |
| Pubmed | ARHGAP32 MYH6 ATP6AP1 PDK1 ACLY DPYSL5 GDI1 NDUFS3 IQGAP1 SACS SV2A PI4KA SLC17A7 PLEKHA5 PLEC FERMT2 CNTN2 CACNA2D1 DMXL2 SORBS2 KTN1 RBP3 NBEA GRM1 NT5DC3 CDC42BPB ARHGAP5 P4HB ICAM5 PRKAR1A ELAVL1 RAPGEF2 DIRAS2 PCM1 | 1.12e-10 | 1431 | 230 | 34 | 37142655 | |
| Pubmed | ARHGAP32 GDI1 IQGAP1 PTPRD PI4KA PLEKHA5 MTCL1 CACNA2D1 DMXL2 SORBS2 KTN1 HECTD4 NBEA GRIK2 SEC31A GRM1 CDC42BPB RABEP1 ICAM5 PRKAR1A PRKAR1B ELAVL1 EML1 RAPGEF2 PCM1 AFF4 PCNT | 3.23e-10 | 963 | 230 | 27 | 28671696 | |
| Pubmed | USP34 ATRX GDI1 RXRG ZBED5 RYR3 IQGAP1 PTPRD SACS SUPV3L1 USP32 PLEC TARBP1 DMXL2 SORBS2 CEP85 HECTD4 NBEA SEC31A CDC42BPB GSK3A ARHGAP5 SNRNP48 RABEP1 PRKAR1A ANKRD36 RAPGEF2 PCM1 AFF4 PCNT | 2.34e-09 | 1285 | 230 | 30 | 35914814 | |
| Pubmed | SYNRG ACLY IRAK1 RUVBL2 KMT2C KIF14 PLEKHA5 CEP85 MAP7D3 KTN1 THOC2 KMT2D RABEP1 ICAM5 TET1 KDM2A IK SPEN PCM1 | 5.66e-09 | 549 | 230 | 19 | 38280479 | |
| Pubmed | PDS5B USP34 ACLY GDI1 IQGAP1 ITPR3 MCM3AP PWP2 KIF14 PDS5A PLEC RFC1 THOC2 DIS3 P4HB ELAVL1 IK SPEN PCM1 PCNT | 1.71e-08 | 653 | 230 | 20 | 22586326 | |
| Pubmed | GRIPAP1 ACLY EVPL IQGAP1 ITPR3 PLEKHA5 PLEC SORBS2 KTN1 CDC42BPB P4HB RABEP1 ELAVL1 KDM2A PCNT | 2.15e-08 | 360 | 230 | 15 | 33111431 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | ZNF217 SPATA2 MCM3AP SCN9A KIF14 CEP85 MAP7D3 KMT2D ZNF746 SPEN PCM1 | 4.62e-08 | 184 | 230 | 11 | 32908313 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATRX TRIM26 DPYSL5 RXRA NDUFS3 PTK6 KMT2C CREB3L2 FOXO3 GALNT10 VPS37A RASA2 APMAP HECTD4 GRIK2 ST3GAL3 CDC42BPB TSEN2 RABEP1 PRKAR1B SNTG2 KDM2A GREB1 UBE3C RAPGEF2 CYP4F11 DNAJC3 PCM1 AFF4 PCNT | 6.32e-08 | 1489 | 230 | 30 | 28611215 |
| Pubmed | USP34 ATRX TRIM26 ZBTB41 MEST KMT2C PI4KA KCNJ8 PLEC MTO1 FERMT2 ARHGEF6 PANK3 RASA2 PRAMEF20 SEC31A RPP14 THOC2 DIS3 ARHGAP5 P4HB TET1 IK AFF4 PCNT | 7.07e-08 | 1084 | 230 | 25 | 11544199 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDS5B ATRX ACLY RUVBL2 NDUFS3 IQGAP1 SUPV3L1 RBM19 PI4KA PWP2 KIF14 PDS5A APMAP KTN1 HAT1 SEC31A RFC1 GRM1 THOC2 AHSA1 DIS3 CLCA2 P4HB PRKAR1A ELAVL1 USP39 UBE3C IK SPEN | 8.67e-08 | 1425 | 230 | 29 | 30948266 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDS5B ACLY IRAK1 EXOC3 RUVBL2 NDUFS3 IQGAP1 ITPR3 SACS PI4KA PWP2 KIF14 PLEC CACNA2D1 APMAP THOC2 P4HB PRKAR1A ELAVL1 USP39 IK SPEN PCM1 PCNT | 9.79e-08 | 1024 | 230 | 24 | 24711643 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | TOGARAM1 EPS8L1 FAT1 RBM19 KIF14 PLEKHA5 MTCL1 DNAH9 RASGRF1 TEX11 ZFHX4 RABEP1 USP39 SPEN | 1.55e-07 | 361 | 230 | 14 | 26167880 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | GRIPAP1 ANKS6 ATRX DPYSL5 EXOC3 DNAAF11 GDI1 DNALI1 IQGAP1 GLB1 SCML1 PTPRQ PLEKHA5 COL14A1 PLEC FERMT2 ARHGEF6 FOXO3 MAP7D3 RBL1 APMAP KTN1 DIS3 P4HB RABEP1 PRKAR1A EXOC2 | 2.31e-07 | 1321 | 230 | 27 | 27173435 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PDS5B PDK1 DPYSL5 RUVBL2 NDUFS3 ZBED5 MEST SACS PDS5A PLEC ARHGEF6 DMXL2 SORBS2 APMAP HECTD4 SEC31A THOC2 SNRNP48 P4HB ELAVL1 USP39 IK SPEN AFF4 | 2.66e-07 | 1082 | 230 | 24 | 38697112 |
| Pubmed | 3.86e-07 | 101 | 230 | 8 | 9872452 | ||
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 4.17e-07 | 182 | 230 | 10 | 31067453 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | PDK1 RGS19 FADD GDI1 RXRA RXRG DNALI1 MEST KMT2C GLB1 PI4KA MCM3AP PDS5A ARHGEF6 FOXO3 COL6A1 SORBS2 RBL1 POGK SEC31A RFC1 RPP14 ZNF746 PRKAR1A | 5.25e-07 | 1124 | 230 | 24 | 21900206 |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | RUVBL2 IQGAP1 PTPN3 SORBS2 HECTD4 HAT1 CPS1 RFC1 RAPGEF2 PCM1 | 6.19e-07 | 190 | 230 | 10 | 15161933 |
| Pubmed | ARHGAP32 EVPL NEB KMT2C PTPN3 MCM3AP PLEKHA5 PLEC KTN1 SEC31A CDC42BPB PRKAR1A PRKAR1B KDM2A RAPGEF2 | 1.01e-06 | 486 | 230 | 15 | 20936779 | |
| Pubmed | 1.14e-06 | 4 | 230 | 3 | 22100703 | ||
| Pubmed | 1.14e-06 | 4 | 230 | 3 | 22419166 | ||
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 1.14e-06 | 4 | 230 | 3 | 18065749 | |
| Pubmed | PDS5B PDK1 ACLY EXOC3 NDUFS3 IQGAP1 MOCS3 PWP2 PDS5A APMAP HAT1 SEC31A RFC1 AHSA1 EXOC2 IK | 1.20e-06 | 560 | 230 | 16 | 35241646 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | PIK3AP1 SYNRG ARHGAP32 GRIPAP1 DPYSL5 IRAK1 SPATA2 RUVBL2 IQGAP1 KIF14 PLEC FERMT2 FOXO3 MAP7D3 GSK3A ARHGAP5 UBE3C GARRE1 PCM1 PCNT | 1.20e-06 | 853 | 230 | 20 | 28718761 |
| Pubmed | USP34 GRIPAP1 SNX3 ANKS6 SPATA2 PTPN3 FAT1 RBM19 PI4KA PDS5A HCFC2 FERMT2 MAP7D3 NBEA SEC31A CDC42BPB RAPGEF2 SPEN PCM1 | 1.21e-06 | 777 | 230 | 19 | 35844135 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG ARHGAP32 SNX3 DPYSL5 PTPN3 PI4KA KIF14 PLEKHA5 MTCL1 PLEC FOXO3 SORBS2 PANK3 MAP7D3 GSK3A RABEP1 TET1 RAPGEF2 GARRE1 PCM1 | 1.38e-06 | 861 | 230 | 20 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 SYNRG ANKS6 IRAK1 ANKLE1 RYR1 ITPR3 KMT2C FAT1 RBM19 PI4KA MCM3AP FGFR2 PLEC FOXO3 HECTD4 CDC42BPB KMT2D TNFAIP2 UBE3C BCAM SPEN PCNT | 1.41e-06 | 1105 | 230 | 23 | 35748872 |
| Pubmed | ARHGAP32 LRRC37A3 NEB GDI1 RYR1 ITPR3 MTCL1 TARBP1 MAP7D3 RASA2 KTN1 NBEA RFC1 ANKRD36B KMT2D USP39 SPEN | 1.43e-06 | 638 | 230 | 17 | 31182584 | |
| Pubmed | SYNRG SCML1 PLEKHA5 MTCL1 MAP7D3 GSK3A TBC1D8 RABEP1 PRKAR1B PCM1 | 1.47e-06 | 209 | 230 | 10 | 36779422 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FAM47A ACLY EVPL ZBTB41 NDUFS3 RYR1 KMT2C AFAP1L2 PI4KA MCM3AP PDS5A MTCL1 KTN1 PCDHB14 NBEA ARHGAP5 RANBP3L USP39 | 2.33e-06 | 736 | 230 | 18 | 29676528 |
| Pubmed | SYNRG ARHGAP32 GRIPAP1 PDK1 RUVBL2 NDUFS3 SV2A PI4KA PLEC FERMT2 DMXL2 SORBS2 KTN1 NBEA NT5DC3 CDC42BPB GSK3A P4HB RABEP1 PRKAR1A PRKAR1B DIRAS2 PCM1 | 2.35e-06 | 1139 | 230 | 23 | 36417873 | |
| Pubmed | ATP6AP1 ATRX TRIM26 RGS19 ZNF217 NDUFS3 IQGAP1 MEST KMT2C RBM19 PI4KA PWP2 KIF14 PDS5A HCFC2 NEBL INTS7 CDKN2AIP KTN1 PCDHB7 CDC42BPB P4HB PRKAR1A EXOC2 IK SPEN AFF4 | 2.52e-06 | 1497 | 230 | 27 | 31527615 | |
| Pubmed | Differential and restricted expression of novel collagen VI chains in mouse. | 2.83e-06 | 5 | 230 | 3 | 21477648 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | EPC2 E2F7 IRAK1 ZNF217 KMT2C PWP2 COL6A1 RBL1 ZFPM2 KMT2D ZFHX4 KDM2A DNAJC3 | 2.91e-06 | 398 | 230 | 13 | 35016035 |
| Pubmed | EPC2 GDI1 KMT2C FAT1 AFAP1L2 MTCL1 MTO1 FTO TARBP1 DMXL2 VPS37A APMAP SEC31A DIS3 P4HB PRKAR1A DNAJC3 | 3.98e-06 | 689 | 230 | 17 | 36543142 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B ACLY EXOC3 RUVBL2 NDUFS3 ZBED5 IQGAP1 SUPV3L1 RBM19 PI4KA MCM3AP PDS5A PLEKHA5 PLEC FERMT2 RASA2 KTN1 SEC31A RFC1 DIS3 P4HB ELAVL1 KDM2A EXOC2 IK | 4.01e-06 | 1353 | 230 | 25 | 29467282 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | SNX3 ATP6AP1 ACLY EVPL EPS8L1 NEB RYR1 IQGAP1 PTPN6 FAT1 GLB1 SCN10A PLCD1 COL6A1 COL6A3 CACNA2D1 NEBL AHSA1 CDC42BPB BCAM SPEN | 4.62e-06 | 1016 | 230 | 21 | 19056867 |
| Pubmed | USP34 IRAK1 ZNF217 KIF14 PLEKHA5 PLEC COL6A1 KMT2D ZFHX4 RABEP1 TET1 PCM1 PCNT | 4.95e-06 | 418 | 230 | 13 | 34709266 | |
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 5.63e-06 | 6 | 230 | 3 | 25966694 | |
| Pubmed | 5.63e-06 | 6 | 230 | 3 | 9068972 | ||
| Pubmed | 5.63e-06 | 6 | 230 | 3 | 20519450 | ||
| Pubmed | 5.63e-06 | 6 | 230 | 3 | 23463619 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 5.63e-06 | 6 | 230 | 3 | 16844763 | |
| Pubmed | ACLY IRAK1 RUVBL2 IQGAP1 PWP2 PDS5A PLEC HAT1 SEC31A THOC2 AHSA1 DIS3 P4HB ELAVL1 USP39 UBE3C | 6.29e-06 | 638 | 230 | 16 | 33239621 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | PDS5B DPYSL5 EXOC3 NEB RYR3 KMT2C USP32 SCN9A PLEKHA5 CDKN2AIP KTN1 NBEA USP39 IK | 6.62e-06 | 497 | 230 | 14 | 36774506 |
| Pubmed | LRRC2 NEB RYR1 COL14A1 PLEC COL6A3 DMXL2 KTN1 SEC31A CDC42BPB P4HB RABEP1 PRKAR1A KDM2A | 6.62e-06 | 497 | 230 | 14 | 23414517 | |
| Pubmed | SNX3 RXRA MEST FAT1 AFAP1L2 KIF14 COL14A1 FGFR2 CNTN2 CREB3L2 COL6A1 COL6A3 SORBS2 CDKN2AIP FAT3 CENPO GRB14 CPS1 RPP14 TSEN2 RAPGEF2 CDH3 DIRAS2 | 6.76e-06 | 1215 | 230 | 23 | 15146197 | |
| Pubmed | ATP6AP1 ATRX PDK1 EXOC3 NDUFS3 ITPR3 GLB1 SACS ERAP2 PI4KA PWP2 PLEKHA5 COL14A1 FERMT2 DMXL2 KTN1 CDC42BPB TBC1D8 MRPS10 NBAS P4HB PRKAR1A PRKAR1B DNAJC3 PCM1 PCNT | 6.79e-06 | 1487 | 230 | 26 | 33957083 | |
| Pubmed | RUVBL2 KMT2C HCFC2 CDC42BPB SNRNP48 KMT2D USP39 IK SPEN PCNT | 7.49e-06 | 251 | 230 | 10 | 31076518 | |
| Pubmed | IRAK1 ITPR3 KCNJ2 SCN9A MTCL1 INTS7 IER2 FICD P4HB PRKAR1A TNFAIP2 RAPGEF2 | 7.76e-06 | 371 | 230 | 12 | 15747579 | |
| Pubmed | 9.80e-06 | 7 | 230 | 3 | 11860456 | ||
| Pubmed | USP34 NEB ITPR3 KMT2C PTPRD PI4KA USP32 SCN10A DMXL2 RGS20 POLI | 1.12e-05 | 322 | 230 | 11 | 26514267 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | SAMD9 TRIM26 ACLY EVPL GDI1 RUVBL2 IQGAP1 ITPR3 PTPN3 RBM19 PWP2 KIF14 PLEKHA5 PLEC MAP7D3 RFC1 THOC2 AHSA1 P4HB ELAVL1 USP39 IK SPEN | 1.16e-05 | 1257 | 230 | 23 | 36526897 |
| Pubmed | Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2. | 1.19e-05 | 45 | 230 | 5 | 27337956 | |
| Pubmed | 1.46e-05 | 79 | 230 | 6 | 18978678 | ||
| Pubmed | Prepubertal testis development relies on retinoic acid but not rexinoid receptors in Sertoli cells. | 1.56e-05 | 8 | 230 | 3 | 17124491 | |
| Pubmed | Elfn1 recruits presynaptic mGluR7 in trans and its loss results in seizures. | 1.56e-05 | 8 | 230 | 3 | 25047565 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.56e-05 | 8 | 230 | 3 | 19033399 | |
| Pubmed | 1.78e-05 | 24 | 230 | 4 | 20301690 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | ATRX IQGAP1 PI4KA SCN9A CACNA2D1 INTS7 GRIK2 ARHGAP5 ELAVL1 USP39 RAPGEF2 DNAJC3 PCM1 | 1.92e-05 | 475 | 230 | 13 | 31040226 |
| Pubmed | 2.08e-05 | 225 | 230 | 9 | 12168954 | ||
| Pubmed | 2.33e-05 | 9 | 230 | 3 | 21775285 | ||
| Pubmed | ARHGAP32 ATP6AP1 EXOC3 ITPR3 PTPN3 PTPN6 PTPRD PI4KA KIF14 FTO CEP85 CDKN2AIP NBEA CDC42BPB GSK3A ARHGAP5 KMT2D P4HB IK PCNT | 2.50e-05 | 1049 | 230 | 20 | 27880917 | |
| Pubmed | EPC2 ATRX E2F7 ZNF217 GDI1 KMT2C MCM3AP HCFC2 MTO1 FOXO3 CEP85 CDKN2AIP CENPO GRIK2 SEC31A TSEN2 NBAS P4HB PRKAR1A ELAVL1 KDM2A PCM1 PCNT | 2.72e-05 | 1327 | 230 | 23 | 32694731 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SYNRG ACLY RUVBL2 RBM19 PLEC FERMT2 CEP85 MAP7D3 KTN1 C16orf96 SEC31A CDC42BPB MTRR KDM2A IK SPEN | 2.95e-05 | 724 | 230 | 16 | 36232890 |
| Pubmed | EPC2 ARHGAP32 ATRX IRAK1 ZNF217 SPATA2 RUVBL2 RXRA KMT2C FAT1 PDS5A HCFC2 CEP85 RFC1 ZFPM2 MRPS10 KMT2D ZFHX4 P4HB ZNF746 ELAVL1 SPEN GARRE1 PCM1 | 2.99e-05 | 1429 | 230 | 24 | 35140242 | |
| Pubmed | ACLY ZNF217 GDI1 RUVBL2 RXRA NDUFS3 IQGAP1 ITPR3 ERAP2 MED26 NEBL KTN1 RFC1 THOC2 AHSA1 DIS3 GSK3A P4HB ELAVL1 IK CDH3 AFF4 | 3.15e-05 | 1247 | 230 | 22 | 27684187 | |
| Pubmed | 3.31e-05 | 10 | 230 | 3 | 23064749 | ||
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | 3.67e-05 | 302 | 230 | 10 | 30561431 | |
| Pubmed | PDS5B ACLY RUVBL2 IQGAP1 ITPR3 GLB1 PI4KA KIF14 PLEC THOC2 ELAVL1 KDM2A USP39 IK PCM1 | 3.83e-05 | 660 | 230 | 15 | 32780723 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 1448119 | ||
| Pubmed | GRASP1 Regulates Synaptic Plasticity and Learning through Endosomal Recycling of AMPA Receptors. | 4.35e-05 | 2 | 230 | 2 | 28285821 | |
| Pubmed | Kendrin/pericentrin-B, a centrosome protein with homology to pericentrin that complexes with PCM-1. | 4.35e-05 | 2 | 230 | 2 | 11171385 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 9489997 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 33188786 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 19851499 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 4.35e-05 | 2 | 230 | 2 | 17118445 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 24138531 | ||
| Pubmed | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 4.35e-05 | 2 | 230 | 2 | 34156443 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 32724043 | ||
| Pubmed | Inwardly rectifying potassium channels: their structure, function, and physiological roles. | 4.35e-05 | 2 | 230 | 2 | 20086079 | |
| Pubmed | Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. | 4.35e-05 | 2 | 230 | 2 | 8026587 | |
| Pubmed | Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. | 4.35e-05 | 2 | 230 | 2 | 16111501 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 12565913 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 9192302 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 7556644 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 27280393 | ||
| Pubmed | CMG2/ANTXR2 regulates extracellular collagen VI which accumulates in hyaline fibromatosis syndrome. | 4.35e-05 | 2 | 230 | 2 | 28604699 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 36869380 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 22114260 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 15364545 | ||
| Pubmed | Central FoxO3a and FoxO6 expression is down-regulated in obesity induced diabetes but not in aging. | 4.35e-05 | 2 | 230 | 2 | 22187289 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 38520674 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 31757807 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 4.35e-05 | 2 | 230 | 2 | 12640042 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 33031748 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 31924266 | ||
| Pubmed | Bethlem myopathy: a series of 16 patients and description of seven new associated mutations. | 4.35e-05 | 2 | 230 | 2 | 30706156 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 14592949 | ||
| Interaction | SYNE3 interactions | SYNRG ARHGAP32 IRAK1 TOGARAM1 SPATA2 ITPR3 ERAP2 KIF14 COL14A1 PLEC SORBS2 CEP85 APMAP NBAS P4HB DNAJC3 GARRE1 PCNT | 2.58e-06 | 444 | 224 | 18 | int:SYNE3 |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.15e-04 | 3 | 154 | 2 | 287 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 1.07e-03 | 53 | 154 | 4 | 103 | |
| GeneFamily | Immunoglobulin like domain containing | 1.34e-03 | 193 | 154 | 7 | 594 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.95e-03 | 206 | 154 | 7 | 682 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.95e-03 | 8 | 154 | 2 | 939 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.50e-03 | 9 | 154 | 2 | 1203 | |
| GeneFamily | Exocyst complex | 2.50e-03 | 9 | 154 | 2 | 1055 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | USP34 ATRX ACLY TOGARAM1 ITPR3 KMT2C PTPN3 SV2A PI4KA HCFC2 CREB3L2 CACNA2D1 DMXL2 VPS37A NEBL RASGRF1 KTN1 HECTD4 NBEA NDFIP1 ARHGAP5 RABEP1 ZNF746 UBE3C EXOC2 DNAJC3 PCM1 AFF4 | 2.10e-08 | 946 | 230 | 28 | M39169 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | ATRX TOGARAM1 ZNF217 PTPN3 FAT1 SACS KIF14 MTCL1 FGFR2 FERMT2 CREB3L2 FOXO3 RAPGEF2 SPEN | 4.76e-07 | 300 | 230 | 14 | M8702 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B USP34 ATRX TOGARAM1 SNX13 FAT1 SACS KIF14 PDS5A MTCL1 FTO FERMT2 CREB3L2 FOXO3 DMXL2 HAT1 THOC2 TDRD7 NBAS RGS20 RAPGEF2 SPEN GARRE1 PCNT | 6.07e-07 | 856 | 230 | 24 | M4500 |
| Coexpression | PECE_MAMMARY_STEM_CELL_DN | 5.37e-06 | 144 | 230 | 9 | M2535 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | PDS5B USP34 SYNRG SNX3 SAMD9 ATRX RGS19 PECAM1 FBXW2 ZNF217 GDI1 ZBED5 IQGAP1 KMT2C PTPN6 ANTXR2 SACS ERAP2 PDS5A ARHGEF6 MAP7D3 RASA2 APMAP KTN1 HECTD4 KMT2D PRKAR1A KDM2A IK SPEN PCM1 | 7.55e-06 | 1492 | 230 | 31 | M40023 |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN | 1.01e-05 | 85 | 230 | 7 | M41085 | |
| Coexpression | GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_UP | EPC2 RGS19 EVPL SNX13 USP32 SCN10A COL6A3 GALNT10 RBL1 TAMALIN | 1.17e-05 | 200 | 230 | 10 | M6367 |
| Coexpression | NRL_DN.V1_DN | 2.25e-05 | 132 | 230 | 8 | M2797 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE | PIK3AP1 ATP6AP1 ACLY PECAM1 RXRA IQGAP1 PTPN6 KCNJ2 RBM19 DMXL2 THOC2 PRKAR1A TNFAIP2 UBE3C | 2.68e-05 | 426 | 230 | 14 | M41019 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 4.42e-05 | 145 | 230 | 8 | M1810 | |
| Coexpression | LEE_BMP2_TARGETS_DN | EMILIN2 E2F7 RUVBL2 RXRA SACS SUPV3L1 RBM19 PWP2 PDS5A COL14A1 MTO1 TARBP1 MMS22L PANK3 HAT1 AHSA1 DIS3 MTRR TNFAIP2 USP39 DNAJC3 | 5.23e-05 | 904 | 230 | 21 | M2325 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | KCNE5 RXRG DNALI1 TMEM132C MEST FAT1 GLB1 PLEKHA5 COL6A1 NEBL FAT3 NDFIP1 ZBBX ARHGAP5 RANBP3L DIRAS2 | 5.25e-05 | 574 | 230 | 16 | M39056 |
| Coexpression | GSE13411_NAIVE_VS_MEMORY_BCELL_UP | 5.31e-05 | 192 | 230 | 9 | M3245 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | EMILIN2 ZNF217 RXRA ANTXR2 GLB1 SELL FOXO3 POGK UBE3C IK SPEN | 6.27e-05 | 294 | 230 | 11 | M40873 |
| Coexpression | GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP | 6.48e-05 | 197 | 230 | 9 | M3343 | |
| Coexpression | LEE_BMP2_TARGETS_DN | EMILIN2 E2F7 RUVBL2 RXRA SACS SUPV3L1 RBM19 PWP2 PDS5A COL14A1 MTO1 TARBP1 MMS22L PANK3 HAT1 AHSA1 DIS3 MTRR TNFAIP2 USP39 DNAJC3 | 6.91e-05 | 922 | 230 | 21 | MM1068 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ATRX SNX13 FAT1 KIF14 PDS5A MTCL1 FTO FERMT2 CREB3L2 FOXO3 TDRD7 RGS20 RAPGEF2 SPEN | 7.05e-05 | 466 | 230 | 14 | M13522 |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN | 7.28e-05 | 200 | 230 | 9 | M8027 | |
| Coexpression | GSE15215_CD2_POS_VS_NEG_PDC_DN | 7.28e-05 | 200 | 230 | 9 | M3521 | |
| Coexpression | LU_AGING_BRAIN_UP | PECAM1 RYR1 IQGAP1 FGFR2 FERMT2 CREB3L2 NEBL RGS20 MTRR GREB1 | 1.18e-04 | 263 | 230 | 10 | M5547 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NEB RYR3 FAT1 PTPRD PTPRQ SCN9A USH2A DNAH9 CNTN2 FAT3 CPS1 GRM1 TEX11 ZFHX4 | 9.14e-13 | 184 | 230 | 14 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NEB RYR3 FAT1 PTPRD PTPRQ SCN9A USH2A DNAH9 CNTN2 FAT3 CPS1 GRM1 TEX11 ZFHX4 | 9.14e-13 | 184 | 230 | 14 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NEB RYR3 FAT1 PTPRD PTPRQ SCN9A USH2A DNAH9 CNTN2 FAT3 CPS1 GRM1 TEX11 ZFHX4 | 9.14e-13 | 184 | 230 | 14 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ATRX NEB PTPRD PLEKHA5 CREB3L2 COL6A1 CACNA2D1 CILP ARHGAP5 ZFHX4 PCM1 | 6.27e-09 | 195 | 230 | 11 | 5c86fddd6d0530beecf45ea5ba6b823123847696 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ARHGAP32 PTPN3 PTPRD SLC17A7 CACNA2D1 FAT3 GRM1 ZFPM2 ZBBX RAPGEF2 | 5.40e-08 | 188 | 230 | 10 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.27e-08 | 191 | 230 | 10 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EMILIN2 FAT1 ANTXR2 COL14A1 FGFR2 COL6A1 CACNA2D1 AQP5 CDH3 ALPK2 | 6.58e-08 | 192 | 230 | 10 | 0dc1f46e40346ed0b286e53b106a812441575100 |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.61e-08 | 195 | 230 | 10 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.61e-08 | 195 | 230 | 10 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | TMEM132C MEST PTPRD COL14A1 COL6A1 COL6A3 CACNA2D1 FAT3 ZFPM2 ZNF385D | 8.38e-08 | 197 | 230 | 10 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.78e-08 | 198 | 230 | 10 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | TMEM132C MEST PTPRD COL14A1 COL6A1 COL6A3 CACNA2D1 FAT3 ZFPM2 ZNF385D | 8.78e-08 | 198 | 230 | 10 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | TMEM132C MEST PTPRD COL14A1 COL6A1 COL6A3 CACNA2D1 FAT3 ZFPM2 ZNF385D | 9.21e-08 | 199 | 230 | 10 | a09292de4c4447b8eee55d401808e43b817321cc |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.36e-07 | 175 | 230 | 9 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 4.47e-07 | 181 | 230 | 9 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.42e-07 | 189 | 230 | 9 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.42e-07 | 189 | 230 | 9 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | TMEM132C PTPRD UGT2B4 COL6A3 CACNA2D1 NEBL FAT3 ZFPM2 RANBP3L | 7.99e-07 | 194 | 230 | 9 | 35f132cc38ac133be01834ed0946188aa0757eb4 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.34e-07 | 195 | 230 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | TMEM132C MEST PTPRD COL14A1 COL6A1 COL6A3 CACNA2D1 FAT3 ZNF385D | 8.70e-07 | 196 | 230 | 9 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | MEST SLC17A7 COL14A1 FERMT2 COL6A1 COL6A3 SORBS2 CILP ZNF385D | 8.70e-07 | 196 | 230 | 9 | fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89 |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | MEST SLC17A7 COL14A1 FERMT2 COL6A1 COL6A3 SORBS2 CILP ZNF385D | 8.70e-07 | 196 | 230 | 9 | ee45e4de9d706ec87094e87f47d3e514539b8092 |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|World / disease group, cell group and cell class | 9.08e-07 | 197 | 230 | 9 | 60fee75b12451206bb2c07b61651a73c59ec6ade | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | TMEM132C MEST COL14A1 COL6A1 COL6A3 CACNA2D1 FAT3 ZFPM2 ZNF385D | 9.47e-07 | 198 | 230 | 9 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.47e-07 | 198 | 230 | 9 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | TMEM132C MEST COL14A1 COL6A1 COL6A3 CACNA2D1 FAT3 ZFPM2 ZNF385D | 9.87e-07 | 199 | 230 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | TMEM132C MEST COL14A1 FERMT2 COL6A1 COL6A3 GRIK2 ZFHX4 GREB1 | 9.87e-07 | 199 | 230 | 9 | 6200618e029063486719479c41eaf31798bd13cf |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.03e-06 | 200 | 230 | 9 | cdaf462b1db29dab61038eeab5ddd3eef3386763 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 160 | 230 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | severe_influenza-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 1.89e-06 | 160 | 230 | 8 | a1181ef36b453eba53b04d836aa9f65a71354cdb | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 160 | 230 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | severe_influenza-CD8+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 1.98e-06 | 161 | 230 | 8 | 82196139cdbbd70a36957a87bc9ac6d02575da3f | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-06 | 162 | 230 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.97e-06 | 170 | 230 | 8 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.53e-06 | 180 | 230 | 8 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.53e-06 | 180 | 230 | 8 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.53e-06 | 180 | 230 | 8 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 4.92e-06 | 182 | 230 | 8 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 5.12e-06 | 183 | 230 | 8 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.55e-06 | 185 | 230 | 8 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | 10x5'-Lung-Mast|Lung / Manually curated celltypes from each tissue | 6.00e-06 | 187 | 230 | 8 | f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0 | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 6.00e-06 | 187 | 230 | 8 | a3592f056e1c2f82ba325fea2ecc4dd6c6347c81 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.00e-06 | 187 | 230 | 8 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | 10x5'-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 6.00e-06 | 187 | 230 | 8 | da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.00e-06 | 187 | 230 | 8 | 8e8b147258982b359447add5027318f5b6d51963 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.00e-06 | 187 | 230 | 8 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.49e-06 | 189 | 230 | 8 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.74e-06 | 190 | 230 | 8 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.01e-06 | 191 | 230 | 8 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-06 | 191 | 230 | 8 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-06 | 191 | 230 | 8 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.28e-06 | 192 | 230 | 8 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.56e-06 | 193 | 230 | 8 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.56e-06 | 193 | 230 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.85e-06 | 194 | 230 | 8 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.85e-06 | 194 | 230 | 8 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.85e-06 | 194 | 230 | 8 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.15e-06 | 195 | 230 | 8 | 157f1f9b0521c9eba11806eb4b6802ff116ab912 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.15e-06 | 195 | 230 | 8 | 95327f2818bcdca53dbd2971f674a9042a1392c6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-06 | 195 | 230 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.15e-06 | 195 | 230 | 8 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.15e-06 | 195 | 230 | 8 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.46e-06 | 196 | 230 | 8 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 8.46e-06 | 196 | 230 | 8 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 8.46e-06 | 196 | 230 | 8 | af9e8f5ef9d03862f707e105857309b55595b1b9 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.46e-06 | 196 | 230 | 8 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.46e-06 | 196 | 230 | 8 | e24a7aaf41793abba66c1189d933ca05b14c1af9 | |
| ToppCell | Caecum-T_cell-Tfh|T_cell / Region, Cell class and subclass | 8.46e-06 | 196 | 230 | 8 | fe2ee5788028e6b671674f0cc50e2b6379f50976 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.46e-06 | 196 | 230 | 8 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.78e-06 | 197 | 230 | 8 | 31c8d6e565bbdc37843ce871fe91845b0cc18a9f | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.11e-06 | 198 | 230 | 8 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | BL-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.11e-06 | 198 | 230 | 8 | 6218a25b94d5fa2c69880539adf9c63bfe52dcd3 | |
| ToppCell | mild_COVID-19-Non-classical_Monocyte|mild_COVID-19 / disease group, cell group and cell class (v2) | 9.11e-06 | 198 | 230 | 8 | d7620b8d24e04ce1c563fc0ebe1625e03fe78950 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 9.46e-06 | 199 | 230 | 8 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.46e-06 | 199 | 230 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.81e-06 | 200 | 230 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.81e-06 | 200 | 230 | 8 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.81e-06 | 200 | 230 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.81e-06 | 200 | 230 | 8 | fc061de0db2e8b5ca47f5e2a1e861018e7f1b582 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.38e-05 | 151 | 230 | 7 | 090b067873740c282865e2d02cf47d5cb3dd7607 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.35e-05 | 164 | 230 | 7 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | Basal_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.54e-05 | 166 | 230 | 7 | aea2ae12e4746149ebc6da063ef694381c098f80 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-05 | 169 | 230 | 7 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.30e-05 | 173 | 230 | 7 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.55e-05 | 175 | 230 | 7 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.55e-05 | 175 | 230 | 7 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 176 | 230 | 7 | 5386386619cf173939d3c117b20e6f27ab397993 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 176 | 230 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 176 | 230 | 7 | 820edade963768e4bfd86b554da4cd7100567ac8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.82e-05 | 177 | 230 | 7 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.82e-05 | 177 | 230 | 7 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.82e-05 | 177 | 230 | 7 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.82e-05 | 177 | 230 | 7 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.94e-05 | 121 | 230 | 6 | 2ae870f822488799cd0ad85e7f72af64e33a867f | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.96e-05 | 178 | 230 | 7 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-05 | 178 | 230 | 7 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.10e-05 | 179 | 230 | 7 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.10e-05 | 179 | 230 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-05 | 179 | 230 | 7 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.25e-05 | 180 | 230 | 7 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| Drug | GTP[S] | RGS19 RYR1 RYR3 IQGAP1 ITPR3 PTPN3 KCNJ2 RBM19 PI4KA KCNJ8 SCN9A SCN10A PLCD1 CACNA2D1 RASA2 HAT1 NBEA GRM1 PRKAR1A IK | 2.66e-06 | 591 | 230 | 20 | CID000001764 |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | RGS19 EPS8L1 PTPN6 PWP2 PLEC MAP7D3 RBL1 TSEN2 IER2 DNAJC3 AFF4 | 5.04e-06 | 195 | 230 | 11 | 953_DN |
| Drug | flecainide | 7.52e-06 | 71 | 230 | 7 | CID000003355 | |
| Drug | KB-R7943 | 7.56e-06 | 47 | 230 | 6 | CID004534086 | |
| Drug | phenytoin | DPYSL5 RYR1 RYR3 ITPR3 MEST SCN9A SCN10A FGFR2 COL6A1 COL6A3 CACNA2D1 | 1.51e-05 | 219 | 230 | 11 | CID000001775 |
| Drug | DM-nitrophen | 1.68e-05 | 16 | 230 | 4 | CID000003083 | |
| Drug | chloro-m-cresol | 1.99e-05 | 6 | 230 | 3 | CID000012008 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 3.37e-05 | 37 | 230 | 5 | CID000009643 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 3.46e-05 | 7 | 230 | 3 | CID009547999 | |
| Drug | Azumoleno | 3.46e-05 | 7 | 230 | 3 | CID000056259 | |
| Drug | Br2BAPTA | 3.46e-05 | 7 | 230 | 3 | CID003081001 | |
| Drug | CHEBI:564108 | 3.46e-05 | 7 | 230 | 3 | CID006400637 | |
| Drug | Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; HL60; HG-U133A | SNX3 MEST PI4KA SCML1 MCM3AP MAP7D3 KTN1 NT5DC3 KDM2A DNAJC3 | 3.53e-05 | 198 | 230 | 10 | 1583_DN |
| Drug | catechin; Down 200; 11uM; MCF7; HT_HG-U133A_EA | SYNRG SPATA2 PTPN6 MOCS3 FGFR2 GALNT10 CDKN2AIP NBEA TSEN2 KDM2A | 3.53e-05 | 198 | 230 | 10 | 1101_DN |
| Drug | tamoxifen citrate; Up 200; 1uM; MCF7; HG-U133A | PDS5A MTO1 FERMT2 MAP7D3 CILP CENPO GSK3A PRKAR1B USP39 DNAJC3 | 3.68e-05 | 199 | 230 | 10 | 143_UP |
| Drug | gadolinium | PECAM1 RYR1 RYR3 ITPR3 SACS RBM19 USH2A CACNA2D1 GRM1 TNFAIP2 | 3.68e-05 | 199 | 230 | 10 | CID000023982 |
| Drug | amiodarone | 3.77e-05 | 160 | 230 | 9 | CID000002156 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 3.88e-07 | 9 | 223 | 4 | EFO_0800562 | |
| Disease | Shortened QT interval | 1.01e-06 | 11 | 223 | 4 | C0151879 | |
| Disease | Sinus Node Dysfunction (disorder) | 4.06e-06 | 15 | 223 | 4 | C0428908 | |
| Disease | pulse pressure measurement | USP34 EPC2 MYH6 PECAM1 ZBTB41 CILP2 PTPRD SCN10A FTO FERMT2 CREB3L2 FOXO3 COL6A1 COL6A3 IQCH NEBL FAT3 NBEA PCDHA3 ZFPM2 ZFHX4 TET1 EML1 IK GARRE1 PCM1 | 2.11e-05 | 1392 | 223 | 26 | EFO_0005763 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.25e-05 | 45 | 223 | 5 | DOID:3748 (is_implicated_in) | |
| Disease | Brugada Syndrome (disorder) | 3.00e-05 | 24 | 223 | 4 | C1142166 | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 5.69e-05 | 2 | 223 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | fibroma | 5.69e-05 | 2 | 223 | 2 | C0016045 | |
| Disease | Fibromatosis | 5.69e-05 | 2 | 223 | 2 | C0016048 | |
| Disease | Ullrich congenital muscular dystrophy (implicated_via_orthology) | 5.69e-05 | 2 | 223 | 2 | DOID:0050558 (implicated_via_orthology) | |
| Disease | Myxofibroma | 5.69e-05 | 2 | 223 | 2 | C0205766 | |
| Disease | Other specified cardiac arrhythmias | 6.72e-05 | 11 | 223 | 3 | C0348626 | |
| Disease | Nodal rhythm disorder | 6.72e-05 | 11 | 223 | 3 | C0264893 | |
| Disease | Ectopic rhythm | 6.72e-05 | 11 | 223 | 3 | C1399226 | |
| Disease | CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder) | 6.72e-05 | 11 | 223 | 3 | C2748542 | |
| Disease | coronary artery disease | PDS5B RGS19 PECAM1 FADD AS3MT LRRC2 SPATA2 SNX13 AFAP1L2 FTO COL6A3 SORBS2 FOXO6 MAP7D3 CDKN2AIP HECTD4 CENPO ZFPM2 PRKAR1A CYP4F3 EML1 RAPGEF2 | 1.15e-04 | 1194 | 223 | 22 | EFO_0001645 |
| Disease | Brugada Syndrome 1 | 1.15e-04 | 13 | 223 | 3 | C4551804 | |
| Disease | Weight Gain | 1.28e-04 | 102 | 223 | 6 | C0043094 | |
| Disease | Primary Erythermalgia | 1.70e-04 | 3 | 223 | 2 | C0014805 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 1.70e-04 | 3 | 223 | 2 | C1833661 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.70e-04 | 3 | 223 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.70e-04 | 3 | 223 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Neuralgia, Supraorbital | 2.22e-04 | 16 | 223 | 3 | C0038870 | |
| Disease | Paroxysmal Nerve Pain | 2.22e-04 | 16 | 223 | 3 | C0751373 | |
| Disease | Nerve Pain | 2.22e-04 | 16 | 223 | 3 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 2.22e-04 | 16 | 223 | 3 | C0751371 | |
| Disease | Neuralgia | 2.22e-04 | 16 | 223 | 3 | C0027796 | |
| Disease | Neuralgia, Atypical | 2.22e-04 | 16 | 223 | 3 | C0234247 | |
| Disease | Neuralgia, Stump | 2.22e-04 | 16 | 223 | 3 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 2.22e-04 | 16 | 223 | 3 | C0423712 | |
| Disease | Neuralgia, Perineal | 2.22e-04 | 16 | 223 | 3 | C0423711 | |
| Disease | Neuralgia, Vidian | 2.22e-04 | 16 | 223 | 3 | C0042656 | |
| Disease | Atrial Fibrillation | 2.25e-04 | 160 | 223 | 7 | C0004238 | |
| Disease | periodontitis | 3.13e-04 | 223 | 223 | 8 | EFO_0000649 | |
| Disease | Colorectal Carcinoma | SLCO1B3 ZNF217 DNALI1 KMT2C FAT1 PTPRD SACS MCM3AP RBP3 HAT1 GRM1 ZNF385D ICAM5 MTRR KDM2A | 3.18e-04 | 702 | 223 | 15 | C0009402 |
| Disease | schizophrenia, intelligence, self reported educational attainment | SAMD9 AS3MT MED26 FOXO3 GALNT10 MMS22L FOXO6 FAT3 HAT1 ST3GAL3 | 3.26e-04 | 346 | 223 | 10 | EFO_0004337, EFO_0004784, MONDO_0005090 |
| Disease | Ullrich congenital muscular dystrophy 1 | 3.38e-04 | 4 | 223 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 3.38e-04 | 4 | 223 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy | 3.38e-04 | 4 | 223 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 3.38e-04 | 4 | 223 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 3.38e-04 | 4 | 223 | 2 | C1834674 | |
| Disease | Short QT Syndrome 1 | 3.38e-04 | 4 | 223 | 2 | C1865020 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 3.38e-04 | 4 | 223 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.71e-04 | 45 | 223 | 4 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 3.71e-04 | 45 | 223 | 4 | EFO_0004623, EFO_0004792 | |
| Disease | carotid plaque build | 4.48e-04 | 84 | 223 | 5 | EFO_0006501 | |
| Disease | squamous cell lung carcinoma, family history of lung cancer | 4.73e-04 | 85 | 223 | 5 | EFO_0000708, EFO_0006953 | |
| Disease | X-23756 measurement | 5.60e-04 | 5 | 223 | 2 | EFO_0022126 | |
| Disease | Sudden death | 5.60e-04 | 5 | 223 | 2 | C0011071 | |
| Disease | bilirubin metabolic disorder (implicated_via_orthology) | 5.60e-04 | 5 | 223 | 2 | DOID:2741 (implicated_via_orthology) | |
| Disease | Attention Deficit Disorder | 5.90e-04 | 22 | 223 | 3 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 5.90e-04 | 22 | 223 | 3 | C1321905 | |
| Disease | serum gamma-glutamyl transferase measurement | PIK3AP1 ATRX IRAK1 SLCO1B3 PTPN3 UGT2B4 FGFR2 FOXO3 SORBS2 IQCH HECTD4 CPS1 CDC42BPB SLCO1B7 TBC1D8 TNFAIP2 ALPK2 | 6.27e-04 | 914 | 223 | 17 | EFO_0004532 |
| Disease | electrocardiography | MYH6 DPYSL5 RXRG PTPN3 KCNJ2 RBM19 SCN10A FGFR2 PLEC CILP INTS7 ZFPM2 | 7.63e-04 | 530 | 223 | 12 | EFO_0004327 |
| Disease | lymphocyte count | PIK3AP1 SYNRG RGS19 IRAK1 JDP2 ZNF217 IQGAP1 CILP2 ANTXR2 SUPV3L1 MCM3AP PLEC MMS22L RBL1 HECTD4 GRB14 CPS1 ZFPM2 RABEP1 ICAM5 BTN2A3P CYP4F3 ADGRE1 | 7.65e-04 | 1464 | 223 | 23 | EFO_0004587 |
| Disease | Attention deficit hyperactivity disorder | 7.67e-04 | 24 | 223 | 3 | C1263846 | |
| Disease | Ischemic stroke, fibrinogen measurement | 8.01e-04 | 55 | 223 | 4 | EFO_0004623, HP_0002140 | |
| Disease | allergic disease | 8.16e-04 | 258 | 223 | 8 | MONDO_0005271 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 8.36e-04 | 6 | 223 | 2 | C1854678 | |
| Disease | 5-methylthioadenosine (MTA) measurement | 8.36e-04 | 6 | 223 | 2 | EFO_0800130 | |
| Disease | Cystic kidney | 8.36e-04 | 6 | 223 | 2 | C0022679 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 8.36e-04 | 6 | 223 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 8.57e-04 | 56 | 223 | 4 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | response to peginterferon alfa-2a | 8.66e-04 | 25 | 223 | 3 | EFO_0010103 | |
| Disease | Cardiac Arrhythmia | 8.66e-04 | 25 | 223 | 3 | C0003811 | |
| Disease | Cholangiocarcinoma | 9.74e-04 | 26 | 223 | 3 | C0206698 | |
| Disease | fibrinogen measurement, factor VII measurement | 9.79e-04 | 58 | 223 | 4 | EFO_0004619, EFO_0004623 | |
| Disease | Adenoid Cystic Carcinoma | 9.91e-04 | 100 | 223 | 5 | C0010606 | |
| Disease | vitamin D measurement | 1.10e-03 | 336 | 223 | 9 | EFO_0004631 | |
| Disease | Congenital Pain Insensitivity | 1.16e-03 | 7 | 223 | 2 | C0002768 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.16e-03 | 7 | 223 | 2 | C0020075 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 1.21e-03 | 28 | 223 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | Mental Retardation, X-Linked | 1.35e-03 | 29 | 223 | 3 | C1136249 | |
| Disease | caudate nucleus volume | 1.49e-03 | 30 | 223 | 3 | EFO_0004830 | |
| Disease | Idiopathic Myoclonic Epilepsy | 1.55e-03 | 8 | 223 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 1.55e-03 | 8 | 223 | 2 | C0338479 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 1.55e-03 | 8 | 223 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 1.55e-03 | 8 | 223 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 1.55e-03 | 8 | 223 | 2 | C0393703 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 1.55e-03 | 8 | 223 | 2 | C0393695 | |
| Disease | Ventricular Fibrillation | 1.55e-03 | 8 | 223 | 2 | C0042510 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.57e-03 | 286 | 223 | 8 | EFO_0004346, EFO_0006930 | |
| Disease | Glioblastoma Multiforme | 1.58e-03 | 111 | 223 | 5 | C1621958 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.68e-03 | 67 | 223 | 4 | EFO_0004286, EFO_0004623 | |
| Disease | asthma | PDS5B TRIM26 E2F7 ZNF217 GLB1 USP32 COL6A3 DMXL2 CEP85 SEC31A RFC1 NDFIP1 POLI PCNT | 1.84e-03 | 751 | 223 | 14 | MONDO_0004979 |
| Disease | congenital heart disease (implicated_via_orthology) | 1.87e-03 | 69 | 223 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | Heart Failure, Diastolic | 1.97e-03 | 33 | 223 | 3 | C1135196 | |
| Disease | 1-ribosyl-imidazoleacetate measurement | 1.98e-03 | 9 | 223 | 2 | EFO_0800034 | |
| Disease | X-21467 measurement | 1.98e-03 | 9 | 223 | 2 | EFO_0020007 | |
| Disease | Myoclonic Epilepsy | 1.98e-03 | 9 | 223 | 2 | C0014550 | |
| Disease | intelligence, self reported educational attainment | 1.99e-03 | 117 | 223 | 5 | EFO_0004337, EFO_0004784 | |
| Disease | multiple sclerosis | JDP2 IQGAP1 GLB1 PLEC FOXO3 MMS22L RASGRF1 CENPO NDFIP1 EXOC2 CDH3 ALPK2 | 2.00e-03 | 594 | 223 | 12 | MONDO_0005301 |
| Disease | eosinophil count | TRIM26 JDP2 SPATA2 GDI1 ITPR3 CILP2 ANTXR2 GLB1 PLEC SELL RASA2 HECTD4 C16orf96 SEC31A CPS1 THOC2 NDFIP1 RABEP1 BTN2A3P POLI EXOC2 ALPK2 | 2.14e-03 | 1488 | 223 | 22 | EFO_0004842 |
| Disease | Parkinsonism (biomarker_via_orthology) | 2.14e-03 | 34 | 223 | 3 | DOID:0080855 (biomarker_via_orthology) | |
| Disease | atrial fibrillation | 2.17e-03 | 371 | 223 | 9 | EFO_0000275 | |
| Disease | sweet beverage consumption measurement | 2.46e-03 | 10 | 223 | 2 | EFO_0010090 | |
| Disease | Epilepsy, Myoclonic, Infantile | 2.46e-03 | 10 | 223 | 2 | C0917800 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.46e-03 | 10 | 223 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.46e-03 | 10 | 223 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | creatine measurement | 2.53e-03 | 36 | 223 | 3 | EFO_0010472 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSTETEEEKAKRLLY | 191 | Q9H6B1 | |
| YLFVSEDKRSVTLDP | 311 | Q96KV6 | |
| VKISRSEKELYATPA | 286 | Q52LR7 | |
| ERKPSEEEYVIRKST | 636 | Q15052 | |
| VVKSSFTYLLLDPRE | 446 | Q8NAG6 | |
| LKETFLTSPEELYRV | 211 | O95433 | |
| VPSLSDILLEESKEY | 1211 | Q86TB3 | |
| LPEETYETKLPSASR | 531 | Q6UY09 | |
| RESDRVYLDLTPVKS | 531 | Q8N4X5 | |
| LEDLKRVSPVGETYI | 106 | P58335 | |
| KFVPRYSLVLELSDS | 356 | Q9HDC9 | |
| EFSLESEIISKLYIP | 361 | A6QL64 | |
| TEYPENLRTLKATIE | 696 | Q8N2N9 | |
| KDYTRALDTLLEQTP | 1806 | Q8TDJ6 | |
| TRLESSYLPSIKEPE | 311 | Q05D60 | |
| PYNTETLDKLLTESL | 291 | Q6ZUJ8 | |
| KTEPSIAEYTVRSKE | 296 | Q13217 | |
| YLAPDATAADKRLTV | 986 | Q9UHB7 | |
| SLSERVAIIKGTYEP | 231 | P55064 | |
| VDEYSDLVTLTKPVI | 1281 | P46940 | |
| SPTEDKILAVFYTIL | 266 | Q8NH16 | |
| VRNLPYTSTEEDLEK | 406 | Q9Y4C8 | |
| LTEYLKVRSHDPEEA | 351 | Q9NTI5 | |
| LTEYLKVRSHDPEEA | 361 | Q29RF7 | |
| YISEETRVLLLTGKP | 1121 | Q29RF7 | |
| EEVYRTQVVEKSLSP | 71 | Q15283 | |
| PDTTEALRELVLKYR | 671 | Q15276 | |
| KLTRYDLLSVLEDPA | 336 | Q86VS3 | |
| LEEVESLNRKYTPVS | 756 | Q9NVH2 | |
| PTELLKAREDSEYLV | 801 | Q9Y4B5 | |
| SYLVLIRITPDEDGK | 506 | P26045 | |
| EKRVADPTLEKYVLS | 1456 | Q14573 | |
| DPTLEKYVLSVVLDT | 1461 | Q14573 | |
| ALSTDSIERLPVYNK | 391 | Q15118 | |
| LLKSRITSEGEYIPL | 231 | P63252 | |
| TSTPEELKIYDSNLR | 791 | Q9UPP5 | |
| ILSPLDRETTDKYTL | 776 | Q14517 | |
| EKEITASPDYLEIAI | 366 | P21802 | |
| TTVYEKLAAPLLERA | 421 | Q15058 | |
| SPLDRESVSAYELVV | 411 | Q9Y5H8 | |
| ARKNYTSTELIIEPE | 1076 | O60309 | |
| SITYKEEEDLTLQPR | 56 | Q9UMX2 | |
| VGVEVSRYPDLSLVK | 4011 | Q8NEZ4 | |
| IDKRSPLYDISATDL | 271 | Q15842 | |
| VDETYALPATKISRV | 556 | Q9Y5Z7 | |
| KKARPITSEESDYLI | 481 | Q86VZ4 | |
| ARKNYTSTELIVEPE | 1076 | A6NM11 | |
| ARKNYTSTELIVEPE | 1076 | A6NMS7 | |
| RILSESLLTPAEYQK | 571 | Q4ZG55 | |
| PEIYLTATDLKRLIS | 346 | Q17R60 | |
| EYLSISEDPKKALVR | 876 | Q6ZRQ5 | |
| PKDLDYLTIRDVSLS | 636 | Q9Y2Z2 | |
| YPKLILREASSVSEE | 46 | Q9C0B1 | |
| YVSDKISLNRSLPDI | 116 | Q86SR1 | |
| YTRSRKLVEAKDEPS | 81 | Q9UJ90 | |
| SDKYDLKTETAPLVV | 41 | Q9UBK8 | |
| ILETRYAVPGKSLEE | 246 | Q9BVA6 | |
| AKLISDYTVTEIPDT | 1526 | O60318 | |
| ERTTTSPKRLLDYHE | 841 | Q8WW38 | |
| PSSALTVEELKYADI | 26 | Q8WYK2 | |
| EKESILLRSSDPDYL | 141 | P16278 | |
| DAPTYTTRDELVAKV | 111 | Q9NXV6 | |
| SSYPEATEKNVERIL | 211 | Q8N140 | |
| ITIEKSPAYFITEEV | 151 | Q8IZT8 | |
| VEDLPLKLTIYSEAD | 1966 | Q15154 | |
| LRDTVAVYLTPESKS | 861 | Q96KP1 | |
| KDVTLTVEYAPALDS | 481 | Q9UMF0 | |
| SPTEDKVLAVFYTIL | 266 | Q8NGY9 | |
| TVYSEVRKAVPDAVE | 711 | P16284 | |
| DLTDPISKERLSYKE | 1981 | Q92817 | |
| IESAPDKRLTLSQIY | 101 | A8MYZ6 | |
| ITVPDTYEARESIVK | 1041 | P42356 | |
| KAYIEDLKERESVPS | 346 | Q9BYS8 | |
| DLKERESVPSYTTKV | 351 | Q9BYS8 | |
| AEIEYLEKTLPFSRS | 71 | P14151 | |
| STYVTEVRELKDLLT | 1221 | Q86UP2 | |
| IKVSYARPSSEVIKD | 91 | Q15717 | |
| KYKPESEELTAERIT | 326 | P07237 | |
| EAYDSSLPLIKAILT | 1231 | Q9Y5S2 | |
| LPEDLTEKLVTYQRS | 331 | Q9P215 | |
| LAIEDSRDKPTYSVL | 1146 | Q9Y4D8 | |
| LPEEYIKTGRLAVDT | 391 | P51617 | |
| VIKRYTARAPDELTL | 266 | A7KAX9 | |
| VKDPSIYDTLESVRS | 231 | Q7Z6J2 | |
| SSLEKYPITKEALEE | 36 | O95402 | |
| LRSTTPEELYQRKIE | 521 | A2RRP1 | |
| VIYTRSSEIEELKAT | 1706 | O95613 | |
| YTQVRSKPDSLEVLL | 146 | Q9UMZ3 | |
| VSEKPSADYVLSVRD | 106 | Q13882 | |
| TLVKLSYFEPIDITA | 21 | Q9H999 | |
| ALSLIERYEPSETAK | 251 | P51178 | |
| DPRYTADLLEVLKTN | 11 | Q86UW1 | |
| YDEAERTKAEATIPL | 76 | Q9BT67 | |
| ITVTDLGTPRLKTEY | 421 | Q9Y5E9 | |
| YTLVTEKPLDRERNT | 401 | Q9Y5E2 | |
| RKPSIVTKYVESDDE | 81 | P46100 | |
| KELSEPSSTRIYAIA | 841 | P31327 | |
| PSSTRIYAIAKAIDD | 846 | P31327 | |
| PERSQEVAYTDIKVI | 111 | P49840 | |
| LDITAEDPSKSYVKL | 271 | O14929 | |
| ETPEEEREKLYNVIS | 131 | Q9Y2K7 | |
| VSASVLPELKRETYG | 381 | Q96AV8 | |
| VLDTSESVALRLKPY | 41 | P12109 | |
| TKYLEATRAIQVSEP | 256 | A6NNT2 | |
| EETITQARYSETLKP | 636 | P54289 | |
| STKDEVIEAVRNLPY | 216 | Q05707 | |
| YSITSRQSLEELKPI | 86 | Q96HU8 | |
| EKPSEYIAAILELSA | 216 | Q9HBI6 | |
| DPEKTLGLVDVLYTA | 471 | O15063 | |
| RTSTSKELYRVLPEA | 211 | Q6P2H3 | |
| EELVKISLSPEYVFS | 1376 | P12111 | |
| LEKEPTYAVVTVDDL | 276 | Q8TDW7 | |
| KTLALLDRERIPVYS | 3086 | Q8TDW7 | |
| VSDTKIDSIEDRYPR | 121 | Q13158 | |
| YLDPLTTVRPKTDEE | 276 | Q68DC2 | |
| VYTSLELPEEIRTHK | 186 | Q9HBK9 | |
| LTALVYSAEEEPRVA | 801 | Q02246 | |
| EKPSEYIAAILELSA | 216 | P78329 | |
| EPSERIKALQDYSVI | 151 | Q86X45 | |
| DSLLKYDTPVLVSRN | 6 | O14645 | |
| YVTVPLRKCTSDELR | 256 | Q8IWC1 | |
| LITYRETSLLFDPKT | 341 | Q6P179 | |
| RASYIKELLQEDTPS | 576 | Q5JRC9 | |
| TEEDAASYVRKVIPK | 106 | P10644 | |
| TEEDAVSYVRKVIPK | 106 | P31321 | |
| KVYSEDETSRALDVP | 111 | Q14449 | |
| RLLYKDLTATLPTDV | 236 | Q9BU64 | |
| GESSSITPLEELYKR | 41 | P31150 | |
| EKPSEYIAAILELSA | 216 | Q08477 | |
| DSYSLEAKVELPTKR | 206 | O00423 | |
| ATLTPERDAYVEAVL | 956 | Q9BXX0 | |
| RPLVARDTSDKYLVL | 556 | Q9NYC9 | |
| LGDITSIPELADYIK | 366 | Q96AC1 | |
| LRAKPPSEAEYTDVL | 306 | Q8TE68 | |
| IKLTDPSLLYLEVST | 666 | O60645 | |
| LEVSTLVSKYPDIRD | 676 | O60645 | |
| TTILEEPYVLFKKSD | 436 | Q13002 | |
| LYRDTPVVKSSSREL | 616 | Q13255 | |
| SYREILREKESSAVP | 671 | Q4V328 | |
| DFASYDILRVIKTPE | 351 | Q9UKT8 | |
| SKTLELRVAYLDPLE | 351 | P50895 | |
| SYKVTELLEEFSPVV | 131 | Q9UNA4 | |
| IVSSLDLYKFSRPEE | 4236 | Q9NZJ4 | |
| LEAELAVEPKTETYV | 236 | P19793 | |
| PAEVEALREKVYASL | 386 | P19793 | |
| APTDQDLITLAKTRY | 3526 | P21817 | |
| YRKTLPRSTVSILDD | 296 | Q5EB52 | |
| VISSGLDREKVPEYT | 281 | P22223 | |
| SPEERVSVTDYKRLL | 331 | O95396 | |
| LTEEEKRTLIAEGYP | 266 | Q70SY1 | |
| VLPDKETSLVDAYEK | 101 | Q9BPU6 | |
| EILGIPSDTTKYLLE | 661 | P23468 | |
| LYLSAKVEALEPEVS | 46 | Q9BTL4 | |
| PLITIAYSDIDIKDA | 486 | Q5HYA8 | |
| ESSPDKRLTLSQIYE | 171 | O43524 | |
| LDRLLIVSTTPYSEK | 351 | Q9Y230 | |
| SEKASPRVTVDDYLV | 451 | Q9Y5W8 | |
| PRVTVDDYLVAKLAD | 456 | Q9Y5W8 | |
| DESTVRRILKDYTKP | 121 | Q8NCE0 | |
| GLDTTLYIPRTADKT | 4976 | O75445 | |
| YVSILSPKEVSLDSR | 146 | P49795 | |
| SDEPDILYKRLSVLV | 66 | P82664 | |
| SSEIDVIKTRIPTYD | 6 | Q9UN30 | |
| VIKTRIPTYDEDDNT | 11 | Q9UN30 | |
| PYSLREVKVSVVDTE | 176 | Q9NRR2 | |
| IIDSSLEDITYVLKP | 181 | Q53GS9 | |
| EYPRKGTTDIAVSEI | 406 | Q8N3T6 | |
| ESLVPDAYKKILETT | 296 | Q9UMZ2 | |
| YLREKEAVITPVASA | 376 | P28749 | |
| EESSYKEIEPVASKR | 326 | P35251 | |
| EDYISILSPKEVSLD | 316 | O76081 | |
| KIDYTKERQPSIDLT | 146 | Q5K651 | |
| YREAKRSTEELVPSI | 61 | Q86UY8 | |
| IRVKTYTDELTPIES | 141 | O75489 | |
| VSKYRDILEPQRETT | 1576 | Q8NFP9 | |
| KLVLSDIDSRYISPE | 236 | Q5VT98 | |
| SYEPITTTLKRKQED | 1876 | Q15858 | |
| SVTKEYRLTPALDSL | 141 | Q11203 | |
| ALHPSISEEERKYIE | 261 | Q9P2U7 | |
| VPARTKTTIALLYDE | 21 | Q9NY99 | |
| SEIHTVLSEEPRYKA | 516 | Q13017 | |
| GYVDLSTIRITPKDS | 191 | G3V0H7 | |
| EVRDYKRLTPISVLD | 341 | Q8IYB8 | |
| KVVVYLVDTSLPDTD | 1066 | Q8NHU6 | |
| SADIETYLLEKSRVI | 261 | P13533 | |
| EETILVSSSYENKRP | 41 | Q5PT55 | |
| DEESLYESSLRIEPK | 1256 | Q13972 | |
| EYVKSLTANPELIDR | 196 | Q9Y2L1 | |
| SIPLYRSSEEEKRVT | 51 | O94875 | |
| VLTVELYPSDKRTTA | 671 | Q7L0J3 | |
| RVESLKLSDSYLDPI | 276 | Q8NFU7 | |
| TPLLDYALEVEKITT | 1001 | P53396 | |
| PAVRTEYLDIESKVI | 426 | Q14246 | |
| IYTVTDQDPRTAKEI | 1076 | O75339 | |
| VYTVTDQSPRLAKEI | 1061 | Q8IUL8 | |
| DDRKLLVSYLPTTVS | 371 | Q9UQC9 | |
| AIELDRTDYKTLPSE | 171 | Q8WZ69 | |
| KASRYSIPDLAVDVE | 496 | Q9Y4G8 | |
| TPELGTAYKLRELVE | 141 | Q9UM82 | |
| SQLDREKDYLAPTTV | 2996 | Q86UP3 | |
| RLQDPSAIKIEVATY | 586 | Q03169 | |
| YLVSDTVLKERLDPE | 116 | Q8NI27 | |
| VLLDKIYSRPDDSVS | 1106 | P10745 | |
| DEKVLPYSNITVREE | 1291 | Q96T58 | |
| VYPVSLTKTEFEDII | 76 | P06133 | |
| ALSLEEPDLEKVVTY | 2151 | Q15413 | |
| ISLTAKILEYSEVAP | 1231 | Q9Y5Y9 | |
| TSSLPELYVEKVLEF | 791 | Q15269 | |
| VRITATDLEDYSIKI | 371 | Q86VV4 | |
| PVTDISDLIRDSYEK | 756 | O95759 | |
| LSTSEEKLVSLPVEY | 756 | Q5SVQ8 | |
| EKLVSLPVEYSSDDK | 761 | Q5SVQ8 | |
| DIGYVDLSTIRITPK | 236 | Q9NPD5 | |
| NPSEVETLREKVYAT | 386 | P48443 | |
| YVKLIQRSSPEADLT | 156 | Q8IYF3 | |
| AVDTSLYILPKEDRE | 281 | Q9NPH0 | |
| KSEDVPYTAALTAVR | 211 | Q15904 | |
| EYADTDIPTTLIRSK | 246 | Q13123 | |
| QDEIIDKSYTPSKIR | 146 | O60493 | |
| RDLEYKTVSVTLDPQ | 306 | Q12899 | |
| LYSELQARETFEKTP | 3361 | Q15149 | |
| DTTEYKLRTLQVSPL | 386 | P29350 | |
| KPDIISRLEEEESYA | 221 | Q9NZV7 | |
| TVKPASLVARDYESL | 581 | Q49AG3 | |
| AVLRVEAEYLSPLDK | 96 | O75362 | |
| EAEYLSPLDKSQVRT | 101 | O75362 | |
| TYISLLPEEIKSSFL | 456 | Q13395 | |
| TLVSLDYAISKPEVL | 131 | Q6NUN9 | |
| ILSLAEEKYRPAALE | 2501 | Q70CQ2 | |
| PRNSLESAEYLKLIT | 1481 | Q9Y4F4 | |
| DAALPLDILTYEEKT | 56 | O95059 | |
| LYKSEPELTTVAEVD | 806 | Q9HAU0 | |
| EFLYDKLREQTLSPT | 1151 | O94979 | |
| SRKSPKSYLEILAEV | 201 | Q6IEG0 | |
| STDDQREDTRIKPIY | 1496 | Q8NFA0 | |
| SSIAEIQKDVEYRLP | 41 | Q8NEZ2 | |
| RPEPSLKIVELDDTY | 386 | A8MT70 | |
| SSIEYSDLSRVPIAK | 221 | Q15386 | |
| SLDYAISKPDILTRI | 181 | Q6ZMS7 | |
| IISSRRIPKGEELTY | 5496 | O14686 | |
| DIPDILRAKRTSEIY | 541 | O76041 | |
| PIVAAKASRDVISDY | 3021 | P20929 |